Fentanyl transdermal - Acrux
Alternative Names: Fentanyl MDTSLatest Information Update: 31 Dec 2021
At a glance
- Originator Acrux
- Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 30 Jan 2009 Discontinued - Phase-I for Pain in Australia (Transdermal)
- 14 Aug 2008 Phase I development is ongoing in Australia
- 12 Aug 2008 KV Pharmaceutical Company licenses MDTS technology from Acrux in the USA